Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:51 UTC |
---|
HMDB ID | HMDB0015061 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Phenoxybenzamine |
---|
Description | Phenoxybenzamine, also known as dibenyline or fenossibenzamina, belongs to the class of organic compounds known as phenylmethylamines. Phenylmethylamines are compounds containing a phenylmethtylamine moiety, which consists of a phenyl group substituted by an methanamine. Phenoxybenzamine is a drug which is used for the treatment of phaeochromocytoma (malignant), benign prostatic hypertrophy and malignant essential hypertension. Phenoxybenzamine is a very strong basic compound (based on its pKa). It is also used in complex regional pain syndrome (CRPS) type 1 due to its anti-adrenergic affects. Phenoxybenzamine forms a permanent covalent bond with adrenergic receptors. This results in further vasodilation, pupil constriction, an increase in GI tract motility and secretions, and glycogen synthesis. This causes vasodilatation in blood vessels, due to its antagonistic effect at the alpha-1 adrenoceptor found in the walls of blood vessels, resulting in a drop in blood pressure. |
---|
Structure | CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1 InChI=1S/C18H22ClNO/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17/h2-11,16H,12-15H2,1H3 |
---|
Synonyms | Value | Source |
---|
Fenossibenzamina | HMDB | Dibenyline | HMDB | Hydrochloride, phenoxybenzamine | HMDB | Dibenylene | HMDB | Dibenziran | HMDB | Goldshield brand OF phenoxybenzamine hydrochloride | HMDB | Link brand OF phenoxybenzamine hydrochloride | HMDB | Esparma brand OF phenoxybenzamine hydrochloride | HMDB | Dibenzyline | HMDB | Phenoxybenzamine hydrochloride | HMDB | Wellspring brand OF phenoxybenzamine hydrochloride | HMDB | Dibenzylin | HMDB | Dibenzyran | HMDB |
|
---|
Chemical Formula | C18H22ClNO |
---|
Average Molecular Weight | 303.826 |
---|
Monoisotopic Molecular Weight | 303.138992038 |
---|
IUPAC Name | benzyl(2-chloroethyl)(1-phenoxypropan-2-yl)amine |
---|
Traditional Name | phenoxybenzamine |
---|
CAS Registry Number | 59-96-1 |
---|
SMILES | CC(COC1=CC=CC=C1)N(CCCl)CC1=CC=CC=C1 |
---|
InChI Identifier | InChI=1S/C18H22ClNO/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17/h2-11,16H,12-15H2,1H3 |
---|
InChI Key | QZVCTJOXCFMACW-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylmethylamines. Phenylmethylamines are compounds containing a phenylmethtylamine moiety, which consists of a phenyl group substituted by an methanamine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Phenylmethylamines |
---|
Direct Parent | Phenylmethylamines |
---|
Alternative Parents | |
---|
Substituents | - Benzylamine
- Phenoxy compound
- Phenol ether
- Phenylmethylamine
- Alkyl aryl ether
- Aralkylamine
- Tertiary aliphatic amine
- Tertiary amine
- Ether
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organic nitrogen compound
- Amine
- Alkyl halide
- Alkyl chloride
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 39 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.01 g/L | Not Available | LogP | 4.7 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Phenoxybenzamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-7930000000-384c032e9b77eb66c749 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Phenoxybenzamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 10V, Positive-QTOF | splash10-0udi-4029000000-388f1c34ddb95b1ee009 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 20V, Positive-QTOF | splash10-0006-9231000000-ec96011b63bed09eb912 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 40V, Positive-QTOF | splash10-0006-9000000000-56a30aa5b92d840f5281 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 10V, Negative-QTOF | splash10-0udi-4029000000-387751e302c4f69be132 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 20V, Negative-QTOF | splash10-0006-9121000000-8f4d9ec9ea1e13488b14 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 40V, Negative-QTOF | splash10-0006-9000000000-6ea07a460948ae16252b | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 10V, Positive-QTOF | splash10-0udi-0009000000-0ae6b7497ff7182fb842 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 20V, Positive-QTOF | splash10-0006-9702000000-5ffc7c8dda8bb19ba742 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 40V, Positive-QTOF | splash10-0006-9200000000-209610c0ebfc4d88a446 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 10V, Negative-QTOF | splash10-001i-9100000000-4d9bc979eb54eab7bcac | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 20V, Negative-QTOF | splash10-000x-9000000000-89136960ac0373c92e2c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Phenoxybenzamine 40V, Negative-QTOF | splash10-0006-9000000000-f58b743d198c36a0fc6f | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00925 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00925 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00925 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 4604 |
---|
KEGG Compound ID | C07435 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Phenoxybenzamine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 4768 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 141434 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Frang H, Cockcroft V, Karskela T, Scheinin M, Marjamaki A: Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors. J Biol Chem. 2001 Aug 17;276(33):31279-84. Epub 2001 Jun 6. [PubMed:11395517 ]
- Caine M, Perlberg S, Meretyk S: A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. Br J Urol. 1978 Dec;50(7):551-4. [PubMed:88984 ]
|
---|